ebola
viru
ebov
filament
envelop
nonseg
negativesens
rna
viru
belong
genu
ebolaviru
famili
filovirida
order
mononegaviral
ebov
highli
pathogen
whose
infect
caus
sever
ebola
viru
diseas
evd
also
known
ebola
haemorrhag
fever
ehf
human
high
mortal
rate
west
africa
experienc
largest
ebola
outbreak
histori
result
case
death
http
moreov
recent
ebola
outbreak
still
ongo
deterior
dr
congo
caus
evd
case
death
april
http
togeth
anoth
filoviru
marburg
viru
marv
ebov
classifi
categori
prioriti
pathogen
impos
signific
threat
global
public
health
http
wwwniaidnihgovresearchemerginginfectiousdiseasespathogen
thu
far
approv
drug
vaccin
commerci
avail
ebov
besid
filovirus
nonseg
negativesens
rna
virus
nnsv
order
mononegaviral
includ
numer
import
human
zoonot
pathogen
rabi
viru
nipah
viru
respiratori
syncyti
viru
human
parainfluenza
virus
measl
viru
mump
viru
etc
nnsv
share
common
organ
viral
genom
rna
similar
strategi
transcript
replic
filovirus
sens
viral
genom
rna
approxim
kb
length
encod
seven
open
read
frame
orf
viral
protein
ie
nucleoprotein
np
viral
protein
glycoprotein
gp
larg
polymeras
protein
l
upon
viral
entri
host
cell
releas
viral
genom
rna
use
templat
transcript
individu
viral
mrna
translat
filovir
protein
viral
genom
rna
switch
replic
antigenom
positivesens
rna
use
templat
product
progeni
viral
genom
rna
transcript
replic
ebov
rna
carri
viral
ribonucleoprotein
rnp
complex
contain
rnadepend
rna
polymeras
rdrp
l
polymeras
cofactor
well
np
repres
minim
element
requir
ebov
transcript
replic
rna
virus
includ
nnsv
viral
genom
antigenom
messeng
rna
contain
multipl
cisact
element
play
critic
role
viral
rna
replic
transcript
translat
packag
viral
life
cycl
similar
cellular
rna
highli
structur
rna
element
need
properli
fold
function
howev
correct
fold
rna
molecul
challeng
sinc
rna
could
kinet
trap
misfold
state
rel
stabl
thermodynam
facilit
correct
fold
rna
varieti
rna
remodel
protein
rna
helicas
rna
chaperon
encod
cell
virus
protein
function
destabil
rnarna
basepair
aid
rna
proper
fold
refold
addit
believ
particip
unwind
viral
doublestrand
rna
dsrna
intermedi
produc
replic
andor
transcript
therebi
facilit
recycl
viral
rna
templat
effici
rna
synthesi
thu
far
wide
rang
positivesens
rna
virus
dsrna
virus
includ
picornaviru
noroviru
flaviviru
alphaviru
coronaviru
reoviru
found
encod
rna
helicas
andor
rna
chaperon
howev
unknown
whether
nnsv
includ
filovirus
encod
protein
rna
remodel
activ
replicationtranscript
nnsv
requir
particip
viral
rna
remodel
activ
appar
discrep
hamper
understand
larg
group
import
pathogen
virus
filovir
essenti
polymeras
l
cofactor
analog
p
protein
nnsv
addit
modular
multifunct
protein
contain
dsrnabind
oligomer
domain
play
pivot
role
filovir
replic
transcript
nucleocapsid
assembl
evas
host
antivir
defens
show
ebov
unexpect
nucleosid
triphosphatas
ntpase
activ
hydrolyz
kind
ribonucleotid
triphosph
ntp
strikingli
ebov
function
like
helicas
unwind
rna
helic
ntpdepend
manner
moreov
found
guanidin
hydrochlorid
guhcl
wellknown
helicas
inhibitor
us
fdaapprov
small
compound
treat
symptom
muscl
weak
fatig
associ
eatonlambert
syndrom
http
wwwaccessdatafdagovscriptscderdafindexcfm
eventoverviewprocess
inhibit
ntpase
helicaselik
activ
dosedepend
manner
importantli
guhcl
also
found
exhibit
inhibitori
effect
replicationtranscript
stabl
ebov
minigenom
replicon
cultur
human
cell
highlight
function
signific
ntpase
helicaselik
activ
ebov
life
cycl
impli
target
helicaselik
activ
novel
strategi
develop
antivir
ebov
construct
pfastbac
htbmbp
pfastbac
htbmbpebov
pfastbac
htbmbpenteroviru
type
pfastbac
htbmbpzika
viru
zikv
describ
previous
cdna
fragment
ebov
genbank
access
amplifi
polymeras
chain
reaction
pcr
plasmid
contain
fulllength
ebov
cdna
cdna
fragment
ebov
zikv
clone
vector
pfastbac
hta
pfastbac
htbmbp
origin
pfastbac
htb
invitrogen
carlsbad
ca
usa
respect
mutat
gener
previous
describ
result
plasmid
subject
bactobac
baculoviru
system
express
recombin
protein
mbp
fuse
ntermin
primer
use
studi
shown
supplementari
tabl
express
purif
protein
baculoviru
system
perform
previous
describ
briefli
cell
infect
recombin
baculovirus
harvest
day
postinfect
cell
pellet
resuspend
lyse
sonic
subject
centrifug
min
g
remov
debri
get
rid
possibl
contamin
copurifi
via
bind
rna
supernat
treat
rnase
omega
final
concentr
h
protein
supernat
purifi
use
amylas
affin
chromatographi
new
england
biolab
ipswich
usa
accord
manufactur
protocol
protein
protein
supernat
purifi
ninta
agaros
column
thermo
fisher
scientif
waltham
usa
accord
manufactur
protocol
purifi
protein
concentr
use
amicon
filter
millipor
schwalbach
germani
store
buffer
exchang
mm
ethanesulfon
acid
hepe
protein
quantifi
bradford
method
store
aliquot
protein
separ
sdspage
visual
coomassi
blue
affinitypurifi
protein
sampl
concentr
tangenti
flow
filtrat
use
amicon
ultra
centrifug
filter
merck
mgml
analysi
size
exclus
chromatographi
concentr
protein
sampl
mix
bsa
control
load
onto
superdex
increas
gl
column
ge
healthcar
preequilibr
buffer
contain
mm
hepeskoh
ph
chromatographi
taken
biolog
duoflow
system
biorad
flow
rate
mlmin
peak
analysi
perform
use
astra
softwar
packag
biolog
chromatographi
system
recombin
baculovirusinfect
cell
resuspend
lyse
sonic
subject
centrifug
min
g
remov
debri
protein
supernat
pull
use
agaros
sigmaaldrich
accord
manufactur
protocol
purifi
atpbound
protein
analyz
western
blot
antimbp
antibodi
ntpase
activ
determin
via
measur
releas
inorgan
phosphat
ntp
hydrolysi
use
direct
colorimetr
assay
previous
describ
gel
mobil
shift
assay
perform
mm
ph
mm
nacl
mm
mm
trna
mm
dtt
u
rnasin
total
volum
reaction
indic
amount
protein
pmol
dsrna
ssrna
dsrna
ssrna
label
digutp
roch
vitro
transcript
deriv
egfp
reaction
incub
min
reaction
termin
addit
sampl
buffer
mm
ph
glycerol
bromophenol
blue
nucleic
complex
separ
electrophoresi
agaros
gel
transfer
hybonda
nylon
membran
ge
healthcar
membran
subject
crosslink
incub
antidigalkalin
phosphatas
antibodi
roch
follow
incub
cdpstar
roch
min
signal
detect
xray
film
fujifilm
tokyo
japan
rna
helix
dna
helix
hybrid
prepar
anneal
two
complementari
nucleic
acid
strand
one
label
end
hexachlorofluorescein
hex
label
strand
unlabel
hexlabel
oligonucleotid
strand
purchas
takara
dalian
china
unlabel
dna
strand
synthes
invitrogen
unlabel
rna
strand
vitro
transcrib
use
rna
polymeras
promega
madison
wi
vitro
transcrib
rna
strand
purifi
polygel
rna
extract
kit
omega
biotek
guangzhou
china
accord
manufactur
instruct
two
strand
mix
proper
ratio
anneal
heat
gradual
cool
previous
describ
result
duplex
examin
nativepag
gel
make
sure
singlestrand
rna
dna
anneal
ratio
standard
r
r
anneal
hexlabel
singl
strand
nonlabel
singlestrand
tail
rna
helix
anneal
hexlabel
singlestrand
nonlabel
singlestrand
anneal
hexlabel
singlestrand
nonlabel
singl
strand
dr
anneal
hexlabel
singlestrand
nonlabel
singlestrand
r
anneal
hexlabel
singlestrand
nonlabel
oligonucleotid
use
studi
list
supplementari
tabl
standard
helix
unwind
assay
perform
previous
describ
minor
modif
briefli
pmol
recombin
protein
pmol
hexlabel
helix
substrat
ad
mixtur
contain
mm
ph
mm
mm
u
rnasin
promega
incub
min
reaction
termin
ad
load
buffer
mm
sd
glycerol
bromophenol
blue
ph
mixtur
electrophores
nativepag
gel
follow
scan
typhoon
imag
ge
healthcar
piscataway
nj
usa
guhcl
sigmaaldrich
serial
dilut
indic
concentr
ad
ebov
minigenom
replicon
seed
plate
plate
cultur
supernat
cell
lysat
plate
harvest
h
posttreat
measur
gluc
activ
rna
level
cell
plate
use
cell
viabil
assay
celltiterglo
luminesc
cell
viabil
assay
kit
promega
madison
wi
usa
use
measur
cell
viabil
drug
treatment
celltiterglo
assay
solut
ad
directli
cultur
medium
cell
grown
plate
incub
plate
shaker
min
dark
transfer
supernat
white
plate
luminesc
measur
use
varioskan
flash
reader
thermo
fisher
scientif
biolux
gaussia
luciferas
assay
kit
new
england
biolab
ipswich
usa
use
measur
gluc
activ
cultur
supernat
harvest
centrifug
g
min
volum
supernat
ad
white
plate
gluc
assay
solut
ad
mix
cultur
supernat
immedi
measur
luminesc
use
varioskan
flash
reader
thermo
fisher
scientif
total
cellular
rna
isol
use
trizol
reagent
tiangen
beij
china
rt
perform
use
revertra
ace
qpcr
rt
kit
follow
protocol
manufactur
toyobo
kyoto
japan
quantit
pcr
carri
util
sybr
green
realtim
pcr
master
mix
toyobo
rt
qpcr
primer
describ
previous
cell
wash
twice
cold
pb
lyse
lysi
buffer
mm
ph
mm
nacl
deoxychol
proteas
inhibitor
cocktail
roch
lysat
subject
sdspage
western
blot
accord
standard
procedur
relev
antibodi
antimbp
antibodi
purchas
mbl
co
ltd
antinp
antibodi
rais
rabbit
previous
describ
northern
blot
perform
previous
describ
minor
modif
five
total
rna
electrophores
denatur
agaros
gel
formaldehyd
capillari
transfer
hybonda
nylon
membran
ge
healthcar
membran
hybrid
diglabel
rna
probe
h
incub
antidigalkalin
phosphatas
antibodi
roch
follow
incub
cdpstar
roch
min
signal
detect
radiographi
xray
film
fujifilm
tokyo
japan
digrna
probe
target
negativestrand
ebov
nt
produc
via
vitro
transcript
use
dig
rna
label
mix
roch
rnaip
perform
previous
describ
minor
modif
briefli
cell
lyse
lysi
buffer
mm
ph
mm
nacl
mm
triton
uml
rnase
inhibitor
promega
proteas
inhibitor
cocktail
roch
min
lysat
clarifi
g
min
postnuclear
lysat
preclear
incub
proteinag
agaros
bead
roch
h
preclear
lysat
incub
antibodi
antiflag
antiigg
togeth
proteinag
agaros
bead
roch
h
antibodybound
complex
wash
five
time
lysi
buffer
final
protein
rna
extract
complex
analyz
northern
western
blot
describ
previou
studi
reveal
ebov
multifunct
protein
dsrnabind
activ
import
abil
suppress
immun
respons
character
ebov
fuse
maltosebind
protein
ntermin
purifi
supplementari
figur
previou
studi
uncov
ebov
oligomer
examin
purifi
oligomer
purifi
via
mbp
column
ionexchang
supplementari
figur
subject
sizeexclus
chromatographi
analysi
use
superdex
column
purifi
protein
elut
major
peak
correspond
molecular
mass
kda
monomer
bsa
use
control
elut
correct
size
kda
supplementari
figur
although
effect
shape
elut
size
exclus
column
make
hard
calcul
exact
molecular
mass
complex
result
indic
purifi
recombin
oligomer
form
number
viral
rna
remodel
protein
also
ntpase
activ
next
examin
ebov
ntpase
activ
hydrolyz
ntp
atp
gtp
ctp
utp
use
sensit
colorimetr
assay
measur
total
amount
free
orthophosph
releas
atp
hydrolysi
data
show
hydrolyz
four
type
ntp
prefer
atp
gtp
utp
ctp
figur
moreov
increas
concentr
incub
atp
effici
hydrolyz
atp
dosedepend
manner
figur
supplementari
figur
furthermor
ntpase
activ
intrigu
examin
protein
ntpbind
activ
data
show
agaros
readili
pulldown
mbp
alon
figur
show
bind
atp
note
mbp
protein
express
purifi
exactli
show
neglig
ntp
hydrolysi
bind
determin
ebov
ntpase
activ
examin
optim
biochem
reaction
condit
includ
differ
salt
content
concentr
ph
use
atp
substrat
data
show
mm
could
support
atpas
activ
effici
follow
figur
show
optim
atpas
activ
presenc
mm
higher
concentr
inhibitori
effect
atpas
activ
importantli
optim
atpas
activ
requir
presenc
atpas
activ
absenc
dival
metal
ion
figur
similarli
ntpase
addit
observ
achiev
optim
atpas
activ
ph
figur
altogeth
data
show
ebov
ntpbind
ntpase
activ
confirm
dsrnabind
activ
incub
protein
artifici
dsrna
construct
anneal
two
complementari
digoxin
dig
label
rna
strand
deriv
egfp
orf
follow
gel
mobil
shift
assay
data
show
mbp
alon
show
dsrna
bind
activ
bind
rna
helix
substrat
dosedepend
manner
supplementari
figur
b
moreov
gener
three
ebovspecif
rna
helix
substrat
contain
nt
ebov
nt
nt
np
orf
ebov
genom
rna
data
show
bind
ebovspecif
rna
helic
supplementari
figur
sinc
ebov
dsrnabind
ntpbind
ntpase
activ
specul
may
serv
put
viral
rna
remodel
protein
examin
rna
helix
unwind
activ
construct
standard
hexlabel
rna
helix
substrat
singlestrand
tail
anneal
short
hexlabel
long
nonlabel
illustr
figur
commonli
use
determin
helixunwind
activ
previous
helixunwind
assay
perform
incub
rna
helix
substrat
standard
unwind
reaction
mixtur
follow
separ
substrat
strand
via
gel
electrophoresi
data
show
hexlabel
rna
strand
effici
releas
rna
helix
substrat
presenc
figur
lane
wherea
helix
substrat
separ
neg
control
mbp
alon
present
figur
lane
note
unwind
reaction
perform
reaction
mixtur
contain
atp
boil
helix
substrat
addit
mbpfusion
wellcharacter
viral
rna
helicas
use
posit
control
helix
unwind
helixunwind
activ
almost
robust
figur
examin
whether
rna
helix
unwind
activ
atpdepend
data
show
could
unwind
rna
helix
presenc
atp
figur
lane
absenc
atp
lane
presenc
nonhydrolys
atp
analog
lane
moreov
result
show
presenc
atp
promot
helixunwind
activ
dosedepend
manner
figur
addit
four
type
ntp
could
enabl
unwind
rna
helix
substrat
prefer
helix
unwind
activ
differ
ntp
consist
ntpase
ctp
least
favor
activ
figur
figur
verifi
activ
also
produc
result
clearli
show
ntpase
helixunwind
activ
supplementari
figur
moreov
rnabind
protein
exclud
possibl
contamin
copurifi
via
cellular
rna
use
rnase
treat
protein
process
protein
purif
remov
possibl
rna
follow
protein
purif
rnafre
show
ntpase
helixunwind
activ
supplementari
figur
taken
togeth
find
show
ebov
ntpdepend
rna
helixunwind
activ
direction
helix
unwind
basic
properti
helicas
find
ebov
rna
helixunwind
activ
sought
assess
helix
unwind
direction
purpos
use
classic
assay
construct
three
differ
rna
helix
substrat
figur
figur
blunt
end
figur
respect
three
helix
substrat
subject
rna
helixunwind
assay
react
purifi
result
show
effici
unwound
rna
helix
bare
unwound
one
figur
moreov
could
unwind
bluntend
rna
helix
figur
like
viral
helicas
determin
unwind
direction
evalu
helixunwind
activ
direct
presenc
increas
concentr
atp
data
show
increas
concentr
atp
fail
promot
unwind
helix
substrat
figur
effici
promot
unwind
helix
substrat
doserespons
manner
figur
conclus
data
demonstr
ebov
abl
unwind
rna
helix
direction
character
optim
biochem
reaction
condit
ebov
purifi
react
standard
rna
helix
substrat
figur
differ
condit
observ
rna
helixunwind
activ
requir
presenc
figur
lane
presenc
could
also
support
helixunwind
much
lesser
extent
figur
lane
hand
although
found
support
ntpase
activ
figur
two
ion
could
support
helixunwind
activ
figur
lane
moreov
increas
concentr
could
promot
helixunwind
activ
doserespons
manner
figur
besid
optim
helixunwind
activ
determin
ph
valu
figur
lane
consist
optim
ph
ntpase
activ
figur
virusencod
rna
helixunwind
protein
also
unwind
dna
helix
andor
hybrid
sought
examin
possibl
ebov
end
gener
four
differ
nucleic
acid
helix
substrat
rna
helix
r
r
dna
helix
hybrid
longer
rna
dna
strand
dr
r
illustr
figur
upper
panel
respect
four
differ
helix
substrat
incub
subject
standard
helixunwind
assay
result
show
could
unwind
rna
helix
r
r
figur
hybrid
dr
figur
longer
rna
strand
hand
could
unwind
dna
helix
figur
hybrid
r
figur
longer
dna
strand
find
indic
helixunwind
activ
ebov
requir
presenc
protrud
singlestrand
rna
helix
substrat
consist
potenti
role
rna
replic
andor
transcript
rna
viru
rna
helixunwind
activ
ebov
ntpdepend
sought
determin
region
respons
ntpase
activ
within
data
show
mutant
delet
aa
fail
hydrolyz
atp
figur
indic
region
highli
conserv
within
multipl
filovirus
supplementari
figur
crucial
atpas
furthermor
examin
helixunwind
dsrnabind
activ
delet
mutant
found
retain
dsrna
bind
activ
figur
fail
unwind
rna
helix
even
presenc
atp
figur
rule
possibl
observ
ntpase
helicaselik
activ
caus
unknown
contamin
via
dsrna
addit
assess
relat
ntpase
activ
dsrnabind
helixunwind
activ
specif
block
ntpase
activ
use
nonhydrolys
atp
analog
consist
data
use
block
ntpase
via
treatment
effici
block
helixunwind
activ
dosedepend
manner
figur
inhibit
dsrnabind
activ
figur
togeth
data
show
ntpase
activ
requir
helixunwind
activ
dsrnabind
activ
ebov
rnabind
activ
import
rna
helixunwind
activ
helicas
sought
assess
whether
dsrnabind
activ
affect
rna
helixunwind
activ
end
two
mutant
construct
includ
delet
mutant
delet
dsrnabind
domain
name
interferon
inhibitori
domain
iid
point
mutant
rkraaa
three
critic
dsrnabind
site
mutat
alanin
figur
supplementari
figur
mutant
protein
express
purifi
recombin
mbpfusion
protein
supplementari
figur
result
show
rkraaa
mutant
complet
lost
dsrnabind
activ
figur
moreov
examin
bind
ebovspecif
dsrna
ectop
express
wt
rkraaa
mutant
cell
togeth
ebov
dsrna
follow
rnaip
use
antiflag
antibodi
data
show
wt
mutant
could
bind
ebov
dsrna
supplementari
figur
addit
examin
rna
helixunwind
ntpase
activ
dsrnabindingdefect
mutant
rkraaa
result
show
mutant
retain
ntpase
activ
figur
hand
unwind
rna
helix
substrat
mutant
fail
figur
togeth
data
present
previous
figur
result
show
dsrnabind
ntpase
activ
independ
helixunwind
activ
requir
dsrnabind
atpas
activ
confirm
observ
helicaselik
atpas
activ
previou
studi
report
guhcl
inhibit
ntpase
helixunwind
activ
helicas
human
noroviru
well
rna
replic
enteroviru
noroviru
thu
sought
assess
whether
ntpase
helicaselik
activ
ebov
also
inhibit
compound
end
atpas
helixunwind
assay
conduct
presenc
increas
concentr
guhcl
data
show
guhcl
could
inhibit
atp
hydrolysi
figur
rna
helixunwind
dosedepend
manner
figur
c
worth
note
inhibitori
effect
guhcl
atpas
helicaselik
activ
ebov
rel
moder
similarli
observ
effect
noroviru
altogeth
guhcl
inhibitor
ntpase
helicaselik
activ
ebov
vitro
helicas
activ
import
replic
divers
virus
thu
would
intrigu
determin
whether
guhcl
also
inhibit
replic
ebov
live
viru
experi
ebov
conduct
biosafeti
level
facil
ebov
minigenom
mg
replicon
system
usual
use
studi
ebov
replic
common
condit
end
util
stabl
ebov
minigenom
replicon
system
ebov
replicon
cell
stabli
replic
transcrib
ebov
minigenom
rna
gaussia
luciferas
gluc
encod
orf
flank
minim
cisel
locat
two
end
ebov
genom
cell
stabli
express
np
l
ebov
replicon
cell
treat
guhcl
indic
concentr
h
examin
cell
viabil
dose
appli
found
obviou
cytotox
concentr
guhcl
mm
figur
mm
guhcl
affect
express
level
np
supplementari
figur
replic
transcript
ebov
minigenom
replicon
examin
measur
level
gluc
activ
minigenom
viral
rna
vrna
crna
complementari
vrna
replic
intermedi
viral
mrna
data
show
replic
transcript
ebov
minigenom
inhibit
guhcl
treatment
dosedepend
manner
figur
f
examin
whether
effect
guhcl
specif
ntpase
helicaselik
activ
due
gener
denatur
effect
ebov
previou
report
antagon
interferon
ifn
respons
viral
suppressor
rna
interfer
vsr
data
show
guhcl
littl
effect
ifn
respons
cell
without
ebov
minigenom
supplementari
figur
affect
vsr
activ
supplementari
figur
moreov
effect
guhcl
zika
viru
zikv
wellknown
monomer
rna
helicas
found
guhcl
affect
neither
helicas
activ
zikv
vitro
replic
zikv
cell
supplementari
figur
data
confirm
effect
guhcl
ebov
ebov
replicon
specif
note
minigenom
replicationtranscript
seem
sensit
guhcl
treatment
biochem
activ
possibl
ebov
minigenom
rna
replic
multiround
process
slight
inhibit
round
result
accumul
effect
besid
compar
transient
transfect
minigenom
system
stabl
ebov
minigenom
replicon
report
show
high
level
activ
minigenom
replic
rel
stabl
even
insensit
ifn
treatment
rna
interfer
probabl
due
persist
replic
strong
viral
rnp
stabil
minigenom
therefor
inhibitori
effect
guhcl
replic
transcript
ebov
minigenom
quit
remark
conclus
result
show
guhcl
abl
inhibit
replic
transcript
ebov
minigenom
replicon
cultur
human
cell
concentr
without
appar
cytotox
rna
remodel
protein
includ
rna
helicas
rna
chaperon
gener
believ
play
critic
role
everi
cellular
process
involv
rna
facilit
correct
fold
refold
rna
molecul
herein
report
first
time
ebovencod
multifunct
protein
ntpase
helicaselik
activ
bind
ntp
hydrolyz
type
ntp
unwind
rna
helic
ntpdepend
manner
moreov
work
show
guhcl
fdaapprov
small
molecul
drug
abl
inhibit
ntpasehelicaselik
activ
vitro
importantli
replic
transcript
stabl
ebov
minigenom
replicon
cultur
human
cell
report
play
pivot
role
multipl
process
filovir
replic
pathogenesi
intrigu
ask
ntpasehelicaselik
activ
function
life
cycl
ebov
cofactor
polymeras
l
essenti
compon
filovir
rnp
complex
carri
ebov
rna
replic
transcript
thu
plausibl
work
togeth
np
l
mediat
unwind
dsrna
intermedi
produc
viral
rna
replicationtranscript
andor
aid
rearrang
cisact
element
within
ebov
mrna
genomicantigenom
rna
therebi
facilit
transcript
translat
encapsid
ebov
rna
allow
viral
rna
switch
among
distinct
process
howev
owe
technic
limit
virusencod
rna
remodel
activ
usual
studi
vitro
mostli
infeas
measur
exact
role
rna
helicas
structur
function
viral
rna
infect
cell
inde
guhcl
fdaapprov
small
compound
wellknown
inhibitor
certain
viral
helicas
includ
enteroviru
noroviru
abl
inhibit
ntpasehelicaselik
activ
ebov
well
ebov
minigenom
replicationtranscript
cell
impli
function
import
rna
remodel
activ
ebov
replic
futur
advanc
techniqu
may
overcom
technic
barrier
provid
mechanist
dynam
view
remodel
viral
rna
molecul
differ
process
ebov
life
cycl
accord
convent
view
helicas
contain
ntpase
activ
util
energi
atp
bind
hydrolysi
melt
nucleic
acid
basepair
thought
particip
atpdepend
rearrang
structur
rna
helicas
gener
classifi
six
superfamili
sf
design
basi
conserv
helicas
motif
interestingli
although
ebov
contain
convent
helicas
motif
ntpasehelicaselik
activ
basic
biochem
characterist
canon
rna
helicas
includ
ntpdepend
requir
dival
metal
ion
direction
helix
unwind
lead
question
whether
canon
conserv
motif
necessari
protein
possess
ntpase
rna
remodel
activ
factual
ectropi
obliqua
picornalik
viru
eov
protein
contain
conserv
motif
commonli
recogn
core
ntp
bind
ntpase
activ
site
helicas
ntpase
activ
eov
depend
motif
addit
capsid
protein
helicoverpa
armigera
genu
cypoviru
famili
reovirida
ntpase
activ
also
hydrolyz
kind
ntp
dntp
contain
conserv
ntpasehelicas
motif
thu
current
studi
togeth
previou
studi
impli
ntpase
rna
remodel
activ
may
strictli
reli
conserv
motif
linear
sequenc
amino
acid
probabl
determin
sophist
activ
site
form
tertiari
protein
structur
current
studi
determin
middl
aa
region
ebov
critic
ntpase
activ
middl
region
belong
ntermin
oligomer
domain
ctermin
iid
whose
structur
resolv
interestingli
although
structur
middl
region
determin
yet
sequenc
align
protein
multipl
filovirus
includ
zair
ebolaviru
ebov
sudan
ebolaviru
sudv
reston
ebolaviru
restv
marv
lloviu
viru
llov
show
region
highli
conserv
within
filovirida
supplementari
figur
predict
secondari
structur
psiblast
base
secondari
structur
predict
psipr
reveal
region
contain
supplementari
figur
besid
motif
scan
use
prosit
profil
via
myhit
http
myhitsisbsibchcgibinmotifscan
suggest
amino
acid
ebov
possibl
protein
kinas
c
pkc
phosphoryl
site
analys
highlight
import
region
structur
function
filovir
futur
studi
reveal
whether
well
put
pkc
phosphoryl
site
critic
ntpasehelicaselik
activ
interest
question
rais
current
studi
rna
remodel
activ
import
virus
helicas
helicaselik
activ
never
found
nnsv
inde
numer
dna
virus
positivesens
rna
virus
found
encod
helicas
share
conserv
ntpasehelicas
signatur
motif
variou
host
helicas
divers
organ
rang
prokaryot
eukaryot
base
conserv
motif
put
helicas
predict
bioinformat
algorithm
biochem
confirm
character
lack
conserv
helicas
signatur
motif
within
ebov
reason
ntpasehelicaselik
activ
predict
identifi
previous
moreov
high
conserv
helicas
signatur
motif
suggest
variou
viral
host
helicas
share
similar
origin
hand
ntpasehelicaselik
activ
ebov
evolv
independ
suggest
filovirus
probabl
nnsv
earlier
evolutionari
diverg
positivesens
rna
virus
latter
acquir
canon
helicas
importantli
absenc
canon
helicas
ebov
manag
obtain
helicaselik
activ
instead
highlight
function
necess
ebov
given
member
filovirida
encod
protein
function
analog
p
protein
nnsv
futur
studi
us
other
investig
whether
ntpasehelicas
activ
gener
filovir
well
nnsv
p
protein
virusencod
helicas
long
consid
potenti
target
antivir
due
import
viral
replic
previou
studi
report
guhcl
effect
inhibit
helicas
activ
enteroviru
human
noroviru
well
replic
enteroviru
human
noroviru
similarli
use
stabl
ebov
minigenom
model
also
found
helicaselik
activ
replic
ebov
minigenom
cell
significantli
inhibit
neglig
cell
toxic
guhcl
guanidin
ubiquit
present
natur
function
mediat
specif
noncoval
bind
variou
catalyt
process
due
physicochem
characterist
guanidin
deriv
use
drug
develop
divers
diseas
potenti
antivir
hepat
c
viru
hcv
human
immunodefici
viru
hiv
flavivirus
guhcl
us
fdaapprov
small
compound
drug
treatment
eatonlambert
syndrom
consid
presenc
multipl
guanidin
deriv
modif
screen
variou
guanidinecontain
compound
probabl
identifi
antivir
compound
better
inhibitori
effect
ebov
ebov
replic
conclus
studi
provid
first
demonstr
ntpasehelicaselik
activ
associ
nnsvencod
protein
ebov
find
guhcl
inhibitor
vitro
ntpase
helicaselik
activ
ebov
also
replicationtranscript
ebov
minigenom
human
cell
find
uncov
unexpect
novel
function
ebov
extend
view
rna
remodel
protein
provid
evid
guanidinecontain
compound
may
serv
potenti
candid
antiebovfiloviru
drug
develop
target
shed
light
understand
ebov
filoviru
replic
pathogenesi
